InMode Ltd. INMD

Updated: 18 Jun 2026

NASDAQ | Technology | Medical aesthetic technology

No signal published yet

We already track InMode and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow InMode free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Technology
Sector
Medical aesthetic technology
We're already tracking InMode Ltd. — here are the latest events we've registered

Recent News

  • On May 20, 2026, InMode announced the appointment of Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer. Earlier in the month, the company reported Q1 2026 revenue of $82 million, a 5% year-over-year increase, while noting margin pressures from new product launches.

What Firelda Watch includes for InMode Ltd.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of InMode Ltd. will be delivered in the same format.

Want to follow InMode Ltd.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow InMode free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

InMode Ltd. INMD
InMode — follow and we'll monitor it
Follow InMode free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.